[ 1 ] Moderna announces it has shipped variant-specific vaccine candidate, mRNA-1273.351, to NIH for clinical study [Internet]. Cambridge: Moderna; 2021 Feb 24 [cited 2021 Feb 26]. Available from: https://investors. modernatx.com/news-releases/news-release-details/moderna-announces-ithas-shipped-variant-specific-vaccine. link1

[ 2 ] COVID-19 virus mutation tracker [Internet]. Thuwal: Computational Bioscience Research Center, King Abdullah University of Science and Technology; 2021 Feb 26 [cited 2021 Feb 26]. Available from: https://www. cbrc.kaust.edu.sa/covmt/. link1

[ 3 ] COVID-19 vaccines were developed in record time—but are these gamechangers safe? [Internet]. Waltham: The Conversation; 2020 Nov 20 [cited 2021 Feb 26]. Available from: https://theconversation.com/covid-19-vaccineswere-developed-in-record-time-but-are-these-game-changers-safe-150249. link1

[ 4 ] About variants of the virus that causes COVID-19 [Internet]. Atlanta: Centers for Disease Control and Prevention; [updated 2021 Feb 12; cited 2021 Feb 26]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/transmission/ variant.html. link1

[ 5 ] Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. Cell Host Microbe 2021;29(3):463–76.e6. link1

[ 6 ] Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. In press. link1

[ 7 ] Understanding how COVID-19 vaccines work [Internet]. Atlanta: Centers for Disease Control and Prevention; [updated 2021 Mar 9; cited 2021 Feb 26]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/ vaccines/different-vaccines/how-they-work.html. link1

[ 8 ] Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. Geneva: World Health Organization; 2021 Feb.

[ 9 ] Duffy S. Why are RNA virus mutation rates so damn high? PLoS Biol 2018;16 (8):e3000003. link1

[10] Abbasi J. COVID-19 and mRNA vaccines—first large test for a new approach. JAMA. 2020;324(12):1125–7. link1

[11] Understanding and explaining mRNA COVID-19 vaccines [Internet]. Atlanta: Centers for Disease Control and Prevention; [cited 2021 Feb 26]. Available from: https://www.cdc.gov/vaccines/covid-19/hcp/mrna-vaccine-basics.html. link1

[12] Answers to all your questions about getting vaccinated for COVID-19 [Internet]. New York City: The New York Times; 2021 Feb 19 [cited 2021 Feb 26]. Available from: https://www.nytimes.com/interactive/2021/ well/covid-vaccine-questions.html. link1

[13] Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, et al. Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol Ther 2017;25(6):1316–27. link1

[14] Regalado A. The next act for messenger RNA could be bigger than COVID vaccines [Internet]. Boston: MIT Technology Review; 2021 Feb 5 [cited 2021 Mar 4]. Available from: https://www.technologyreview.com/2021/02/05/ 1017366/messenger-rna-vaccines-covid-hiv/. link1

[15] Liu A. An mRNA vaccine delivered in hydrogel shows promise as a durable cancer immunotherapy [Internet]. Framingham: Fierce Pharma; 2021 Feb 17 [cited 2021 Mar 4]. Available from: https://www.fiercebiotech.com/ research/mrna-vaccine-delivered-hydrogel-shows-promise-as-a-durable-cancerimmunotherapy. link1

[16] Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 2020;383 (27):2603–15. link1

[17] Past seasons vaccine effectiveness estimates [Internet] Atlanta: Centers for Disease Control and Prevention; 2020 Jan 29 [cited 2021 Mar 4] Available from: https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates. html. link1

[18] Wu KJ. The body is far from helpless against coronavirus variants [Internet]. Washington, DC: The Atlantic; 2021 Feb 12 [cited 2021 Feb 26]. Available from: https://www.theatlantic.com/science/archive/2021/02/ antibody-evolution/618004/. link1

[19] Hewitt EW. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 2003;110(2):163–9. link1

[20] Sadoff J, Le Gars M, Shukarev G, Heerwegh D, Truyers C, de Groot AM, et al. Interim results of a phase 1–2a trial of Ad26.COV2.S COVID-19 vaccine. N Engl J Med 2021. In press. link1

[21] Ahi YS, Bangari DS, Mittal SK. Adenoviral vector immunity: its implications and circumvention strategies. Curr Gene Ther 2011;11(4):307–20. link1

[22] Weintraub A. Pfizer and Moderna haven’t proven their COVID-19 vaccines shield against new variants: analysts [Internet]. Framingham: Fierce Pharma; 2021 Jan 28 [cited 2021 Feb 26]. Available from: https://www. fiercepharma.com/pharma/pfizer-and-moderna-have-not-yet-proven-theircovid-19-vaccines-shield-against-new-variants. link1

[23] Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. In press.

[24] Ledford H. How ‘killer’ T cells could boost COVID immunity in face of new variants [Internet]. London: Nature; 2021 Feb 12 [cited 2021 Mar 4]. Available from: https://www.nature.com/articles/d41586-021-00367-7. link1

[25] Eddy M. An Austrian region becomes a coronavirus vaccine laboratory [Internet]. New York City: The New York Times; 2021. Mar 4 [cited 2021 Mar 8]. Available from: https://www.nytimes.com/2021/03/04/world/europe/ austria-south-africa-variant.html?smid=em-share. link1

[26] Lambert J. The UK approved the world’s first COVID-19 human challenge trial [Internet]. Washington, DC: Science News; 2021 Feb 18 [cited 2021 Mar 4]. Available from: https://www.sciencenews.org/article/coronavirus-uk-firsthuman-challenge-trial-covid-19. link1

[27] Weiss P. Pandemic woes: antigen tests to the rescue? Engineering 2021;7 (1):3–5. link1

[28] Genomic surveillance for SARS-CoV-2 variants [Internet]. Atlanta: Centers for Disease Control and Prevention; [updated 2021 Feb 2; cited 2021 Feb 26]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/ variant-surveillance.html. link1

[29] Chappell B. COVID-19 vaccine makers’ booster shots aim at a moving target: coronavirus variants [Internet]. Washington, DC: National Public Radio; 2021 Feb 25 [cited 2021 Mar 8]. Available from: https://www.npr.org/sections/ health-shots/2021/02/25/971345409/covid-19-vaccine-makers-booster-shotsaim-at-a-moving-target-coronavirus-variant. link1

[30] Pfizer and BioNTech initiate a study as part of broad development plan to evaluate COVID-19 booster and new vaccine variants [Internet]. New York: Pfizer; 2021 Feb 25 [cited 2021 Mar 4]. Available from: https://www.pfizer. com/news/press-release/press-release-detail/pfizer-and-biontech-initiate-studypart-broad-development. link1

[31] Garde D, Herper M. Moderna ready to test version of COVID-19 vaccine aimed at worrisome variant [Internet]. Boston: STAT News; 2021 Feb 24 [cited 2021 Feb 26]. Available from: https://www.statnews.com/2021/02/24/modernaready-to-test-version-of-covid-19-vaccine-aimed-at-worrisome-variant/. link1

[32] Lupkin S. FDA aims to be ‘nimble’ on COVID-19 vaccine changes for variants [Internet]. Washington, DC: National Public Radio; 2021 Feb 11 [cited 2021 Mar 8]. Available from: https://www.npr.org/sections/health-shots/2021/02/ 11/966510470/fda-aims-to-be-ni. link1

[33] Oakes K. How to handle COVID variants? Global regulators turn to flu vaccines [Internet]. Rockville: Regulatory Focus; 2021 Mar 4 [cited 2021 Mar 8]. Available from: https://www.raps.org/news-and-articles/news-articles/2021/ 3/how-to-handle-covid-variants-tur. link1